Acrospire Investment Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-2,796
| Closed | -$15K | – | 128 |
|
|
2017
Q2 | $15K | Sell |
2,796
-3,099
| -53% | -$16.6K | 0.01% | 1658 |
|
|
2017
Q1 | $34K | Sell |
5,895
-22,288
| -79% | -$129K | 0.03% | 1264 |
|
|
2016
Q4 | $112K | Buy |
28,183
+14,058
| +100% | +$55.9K | 0.05% | 841 |
|
|
2016
Q3 | $51K | Sell |
14,125
-75
| -0.5% | -$271 | 0.03% | 1056 |
|
|
2016
Q2 | $87K | Buy |
14,200
+10,600
| +294% | +$64.9K | 0.06% | 575 |
|
|
2016
Q1 | $18K | Buy |
+3,600
| New | +$18K | 0.01% | 1562 |
|